美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Nasdaq Biotechnology ETF

34.36

+0.10590.31%

盤後：34.35-0.0059-0.02%19:59 EDT

成交量：1.97萬

成交額：67.75萬

市值：9,550.94萬

市盈率：- -

高：34.62

開：34.39

低：34.20

收：34.25

52周最高：36.84

52周最低：23.42

股本：278.00萬

流通股本：278.00萬

量比：0.95

換手率：0.71%

股息：0.26

股息率：0.75%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌

中藥創新從「經驗方」走到「數據方」

安進(AMGN)股票9月8日盤中下跌8.33%：真相來了

TradingKey中文

BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華

更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期

阿斯利康慢阻肺藥物兩項晚期臨床試驗取得成功

环球市场播报

安進股價下跌7%，創下自2025年6月以來最大單日跌幅。

DELPHI‑305 三期臨床試驗達到主要終點。

Tozorakimab在OBERON和TITANIA兩項Ⅲ期臨床試驗中，在降低慢阻肺病急性加重方面均顯示出統計學和臨床意義上的顯著改善

兩項驗證性試驗迎突破性結果！阿斯利康Tozorakimab再傳好消息

更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標

安進Phase 3 Dellphi-305研究重大突破：總生存期獲益顯著優於度伐利尤單抗單藥治療

Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善

BMO下調安進及BioNTech評級至「與大市同步」

苑東生物：公司將於9月16日參加科創板2026年半年度創新藥行業集體業績説明會

禮邦醫藥-B(09637)：AP308治療IgA腎病的新藥臨床試驗申請獲美國食品藥品監督管理局批准

美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾

老虎资讯综合

AI 製藥迎來價值兑現期，創新藥產業打開全新增長空間

独角兽智库

PHARVARIS的3期臨床試驗達到全部主要及次要終點。

石藥集團：SYH2083滴眼液獲臨床試驗批准

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/IBBQ/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.3559,"timestamp":1789588800000,"preClose":34.25,"halted":0,"volume":19691,"hourTrading":{"tag":"盘后","latestPrice":34.35,"preClose":34.3559,"latestTime":"19:59 EDT","volume":40,"amount":1379.2795,"timestamp":1789603165220,"change":-0.0059,"changeRate":-0.000172,"amplitude":0},"delay":0,"changeRate":0.003091970802919659,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"已收盤","change":0.1059,"latestTime":"09-16 16:00:00 EDT","open":34.39,"high":34.62,"low":34.1992,"amount":677542.144902,"amplitude":0.012286,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":34.25,"sharesOutstanding":2520001,"nav":34.27126,"aum":95274137.07126,"dividendRate":0.007478,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.28,"preClose":34.25,"latestTime":"09:29 EDT","volume":69,"amount":2360.8497660000003,"timestamp":1789565397037,"change":0.03,"changeRate":0.000876,"amplitude":0.008175},"postHourTrading":{"tag":"盘后","latestPrice":34.35,"preClose":34.3559,"latestTime":"19:59 EDT","volume":40,"amount":1379.2795,"timestamp":1789603165220,"change":-0.0059,"changeRate":-0.000172,"amplitude":0},"volumeRatio":0.950696,"impliedVol":0.1125,"impliedVolPercentile":0.4741},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.950696,"shares":2780001,"dividePrice":0.2569,"high":34.62,"amplitude":0.012286,"preClose":34.25,"low":34.1992,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.3559,"eps":0,"divideRate":0.007478,"volume":19691,"delay":0,"ttmEps":0,"open":34.39,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.9277,"twentyDayClose":34.6197,"sixtyDayClose":30.4995},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666371445","title":"諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371445","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371445?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 00:41","pubTimestamp":1788885660,"startTime":"0","endTime":"0","summary":"——Royalty Pharma** RPRX重申“其2030年投资组合收入目标为47亿美元或更高”** 计入本交易日涨幅，该股今年以来累计上涨54.7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4501DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","AMGN","BK4585","IBBQ","BIB","RPRX","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","LU0058720904.USD","LU1057294990.SGD","BK4007","LU0320765992.SGD","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","IONS","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666654371","title":"中藥創新從「經驗方」走到「數據方」","url":"https://stock-news.laohu8.com/highlight/detail?id=2666654371","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666654371?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 23:28","pubTimestamp":1788881280,"startTime":"0","endTime":"0","summary":"传统中药源于历代医家的经验积累，但面对现代医学的检验标准，如何用可重复、可量化的数据证明其安全性和有效性，始终是中药现代化进程中绕不开的一道题。近期，《证券日报》记者在梳理相关上市公司公告时注意到，有一个词被越来越多的中药企业频繁提及——循证医学。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083868422064.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083868422064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","MEDX","BK1574","BK4159","06978","LNGR","RCT","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376637","title":"安進(AMGN)股票9月8日盤中下跌8.33%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376637","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376637?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 22:16","pubTimestamp":1788876978,"startTime":"0","endTime":"0","summary":"• 诺华 pelacarsen 试验失败，加大了安进竞品 olpasiran 的临床不确定性。\n• 出于对估值的担忧，BMO Capital 将安进的评级从“跑赢大盘”下调至“与大盘持平”。\n• 技术指标显示，安进的 RSI 为 40.256，威廉指标（Williams %R）为 97.857。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156239-market-movers-amgn-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0109394709.USD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","PJP","IBB","BK4566","LU2112291526.USD","BK4139","LU2242646821.SGD","BK4599","LU1023059063.AUD","BK4533","LU0320765992.SGD","LU1983299246.USD","PBE","LU0889565916.HKD","BIB","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4534","AMGN","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU2468319806.SGD","IBBQ","BBH","BK4588","IE0009355771.USD","LU0868494617.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4581","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月8日-周二开盘时，华尔街主要股指涨跌不一，中东地区新一轮冲突推动油价升至7月下旬以来的最高水平，而市场正在等待本周晚些时候","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","LU0011850046.USD","IONL","LU1989772923.USD","LU2362540622.SGD","BK4533","BK4597","LU1057294990.SGD","LU2506952097.USD","SGML","IE00BLSP4452.SGD","LU0170899867.USD","ICLN","LU0029874061.USD","LU0444973449.USD","LU1861558580.USD","LU0266013472.USD","PTH","SEI","WQTM","BK4585","IE00B19Z3B42.SGD","IE00BBT3K403.USD","PJP","IOYY","LU0138981039.USD","LU0868494617.USD","LU1861559042.SGD","BK4170","BEZ","LU1989771016.USD","LU0122379950.USD","LU0225284248.USD","SG9999003800.SGD","SGXZ57979304.SGD","SRPT","BK4581","LU1791710582.SGD","LU2242652126.USD","PFE","LU1303367103.USD","BEC","LU1815336760.USD","LU0225283273.USD","IE0009354923.USD","LU1791710400.SGD","HYDR","LU0889565916.HKD","LU2244417387.USD","IE00B66KJ199.SGD","BK4556","QTUP","BK4548","LU0058720904.USD","BK4602","IE00B19Z4B17.USD","LU0823417737.USD","BK4592","IE00B3T34201.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","ABM","LU2089984988.USD","WATS","MEDX","BK4120","CQTM","BK4591","BK4541","IE0031619046.USD","BK4121","IE0009355771.USD","LU0957808578.USD","SG9999011175.SGD","BK4124","LU0528227936.USD","PBE","SG9999001440.SGD","SMOG","LU1066053197.SGD","GNMX","BK4007","IE00B4R5TH58.HKD","LU1720051108.HKD","LU2506951792.HKD","LU0187121727.USD","LU1989764748.USD","LU0114720955.EUR","RGTU","IONZ","LU1291159041.SGD","BK4568","CNRG","LU2112291526.USD","LU2362541513.USD","IE00BLSP4239.USD","LU2506952170.USD","RGTI","SG9999002232.USD","TBXU","BE","BEX","LU0444971666.USD","LU1366192091.USD","IE0002141913.USD","IONS","LU2357125470.USD","LU0208291251.USD","LU0456855351.SGD","CHRW","LU1989764664.SGD","IE000M9KFDE8.USD","LU2242649171.HKD","BEG","LU0353189763.USD","LU0345769631.USD","LU1894683264.USD","IBBQ","LU0109394709.USD","EGGY","LU0823414478.USD","OIH","IE0002270589.USD","LU1894683348.USD","IE00B2B36J28.USD","04332","LU1548497426.USD","LU1804176565.USD","LU1988902786.USD","LU0070302665.USD","BK4532","LU0878866978.SGD","LU2468319806.SGD","LU2294711713.HKD","LU1642822529.SGD","LU2543165471.USD","LU2596442595.SGD","ZAP","UPGR","BK4534","LU0950375773.USD","BK4504","LU0433182093.SGD","IBB","SG9999013999.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","IONQ","BK4139","LU0823416689.USD","BK4535","LU2087625088.SGD","IONX","LU0882574055.USD","PHVS","LU0267386448.USD","GNOM","BSX","LU1571399168.USD","LU1983299246.USD","SG9999001176.USD","LU2264538146.SGD","LU2098885051.SGD","LU0432979614.USD","LU1153585028.USD","LU0823414551.USD","LU1093756325.SGD","BBH","BK4182","LU0321505439.SGD","LU1023059063.AUD","RGYY","VCLN","LU0068578508.USD","LU0823417653.USD","LU1093756168.USD","BK4550","LU2265009873.SGD","LU2242646821.SGD","BK4505","CTEC","LU1883839398.USD","RGTZ","LU2324357040.USD","LU0306806265.USD","UNFI","BK4168","LU0345769128.USD","LU0128526141.USD","DYN","LU0306807586.USD","BK4082","AMGN","LU2491049909.HKD","VTWG","IE00B19Z3581.USD","ALV","SRPU","LU1064131342.USD","BK4567","IONC","ILMN","IE0034235188.USD","LU0320765489.SGD","BIB","BK4179","LU0048584097.USD","LU2506951958.HKD","LU2491050071.SGD","LU0353189680.USD","LU2491050154.USD","LU2249611893.SGD","NVS","RGTX","BK4141","BK4588","IE00BFTCPJ56.SGD","LU0238689110.USD","ROIV","RGTC","LU1061106388.HKD","LU0234572021.USD","SHAK","LU0985481810.HKD","LU0289739699.SGD","LU1489326972.SGD","BK4209","BK4131","LU2362541273.HKD","SG9999001176.SGD","LU0320765992.SGD","SIMS","BHVN","IBAT","LU0077335932.USD","LU0251132253.USD","LU0476273544.USD","LU1718418525.SGD","LU2357305700.SGD","BK4578","SG9999002224.SGD","LU0211331839.USD","LU2506951875.HKD","NTLA","OZEM","USNG","BK4599","LU0321505868.SGD","PPH","XES","BK4566","LU1989772840.SGD","BK4102","FRNW","LU0225771236.USD","LU1878469433.USD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665251375","title":"更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=2665251375","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665251375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:52","pubTimestamp":1788875520,"startTime":"0","endTime":"0","summary":"更新版 1-阿斯利康的联合用药方案在晚期研究中帮助肺癌患者延长了生存期全文补充了有关临床试验和背景的详细信息路透9月8日-阿斯利康AZN.L周二表示，其抗癌药物Imfinzi与安进的AMGN.O靶向免疫疗法Imdelltra联合使用，在一项晚期临床试验中显著提高了广泛期小细胞肺癌患者的总生存期。癌症治疗药物占阿斯利康销售额近一半；2025年，在该公司256.2亿美元的肿瘤产品收入中，Imfinzi贡献了60.6亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T45013T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU2468319806.SGD","BK4585","LU0997586432.USD","LU1196032939.SGD","PJP","LU0823416689.USD","IE00B3T34201.USD","LU2108987350.USD","LU0029864427.USD","LU0557290698.USD","IE0009355771.USD","AMGN","LU1267930227.SGD","LU0738911758.USD","BK4533","LU0289739699.SGD","IBB","LU0889566641.SGD","LU1153585028.USD","LU2089284900.SGD","LU2237443622.USD","LU0171293334.USD","BK4588","TBXU","LU0211327993.USD","LU0708994859.HKD","LU0969580561.USD","BBH","LU0211328371.USD","PBE","LU0553294199.USD","LU1273509221.SGD","LU1267930490.SGD","LU0158827948.USD","LU0784384876.USD","LU2237443382.USD","LU2242646821.SGD","AZN.UK","LU2125909593.SGD","LU1046234339.USD","03165","LU0211326755.USD","LU0792757196.USD","LU1267930813.SGD","LU2279689827.SGD","IBBQ","LU0058720904.USD","LU0887340254.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665754133","title":"阿斯利康慢阻肺藥物兩項晚期臨床試驗取得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2665754133","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665754133?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:45","pubTimestamp":1788875100,"startTime":"0","endTime":"0","summary":"阿斯利康周二公布慢阻肺在研药物两项成功的晚期临床试验完整结果，市场对该药创造数十亿美元营收的预期进一步升温。据阿斯利康数据，美国确诊及未确诊慢阻肺患者合计约 1600 万2600 万人，慢阻肺位列美国第五大死亡原因。阿斯利康近期将该药物销售峰值预期上调至50 亿美元以上，助力公司冲刺 2030 年整体 800 亿美元营收目标。两项临床试验同时纳入现吸烟者、既往吸烟者，覆盖全部嗜酸粒细胞水平、全部肺功能严重程度分级的患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrns9296776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BMED","IBBQ","PSYK","MDTX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375527","title":"安進股價下跌7%，創下自2025年6月以來最大單日跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:30","pubTimestamp":1788874246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1023059063.AUD","IBBQ","AMGN","LU0889565916.HKD","BK4588","LU0320765992.SGD","IBB","LU0868494617.USD","LU0058720904.USD","BK4139","PBE","BK4533","BIB","IE0002141913.USD","IE00B4R5TH58.HKD","LU1983299246.USD","IE0009355771.USD","BK4566","LU0109394709.USD","BK4581","SG9999001440.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2242646821.SGD","LU2468319806.SGD","PJP","LU1571399168.USD","TBXU","BBH","LU2242652126.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4599","LU2112291526.USD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373053","title":"DELPHI‑305 三期臨床試驗達到主要終點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373053","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373053?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:19","pubTimestamp":1788873564,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BMED","IBBJ","MDTX","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968376","title":"Tozorakimab在OBERON和TITANIA兩項Ⅲ期臨床試驗中，在降低慢阻肺病急性加重方面均顯示出統計學和臨床意義上的顯著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968376","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968376?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:18","pubTimestamp":1788873480,"startTime":"0","endTime":"0","summary":"OBERON和TITANIA两项Ⅲ期试验的结果令人鼓舞，证实tozorakimab在广泛患者人群中均能降低急性加重风险，有望帮助患者摆脱反复急性加重的困扰，获得全新的治疗选择。Tozorakimab 是首个在广泛慢阻肺病患者人群中显示出减少气道黏液栓堵塞作用的生物制剂3。Tozorakimab总体耐受性和安全性良好，唯一报告的药物不良反应为注射部位反应1,2。目前，tozorakimab已在欧盟、中国等主要市场进入上市许可审评阶段，用于治疗慢性阻塞性肺疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5042444_ZH42444_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5042444_ZH42444_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["AZN","LU2237443382.USD","LU2089984988.USD","LU0109394709.USD","LU0058720904.USD","LU2237443622.USD","LU2462157665.USD","MDTX","LU2456880835.USD","LU1267930573.SGD","LU2237443978.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU2237443549.SGD","LU0889565916.HKD","LU2236285917.USD","LU0432979614.USD","BK4568","AZNH","LU2237443465.HKD","BMED","LU0289739699.SGD","LU0029864427.USD","PSYK","BK4585","LU2468319806.SGD","IBBQ","BK4588","LU1829250122.USD","LU0128525929.USD","IBBJ","LU2417539215.USD","LU0310800379.SGD","LU2237443895.HKD","BK4007","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665137530","title":"兩項驗證性試驗迎突破性結果！阿斯利康Tozorakimab再傳好消息","url":"https://stock-news.laohu8.com/highlight/detail?id=2665137530","media":"上观新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665137530?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:14","pubTimestamp":1788873273,"startTime":"0","endTime":"0","summary":"慢性阻塞性肺疾病候选药物Tozorakimab再度传来好消息：其在最新两项验证性试验中都展示出了突破性结果，有望为全球数百万接受标准吸入治疗后仍面临急性加重风险的患者带来新的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083868309733.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083868309733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBBQ","BEZ","BEC","BEG","BEX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665732793","title":"更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665732793","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665732793?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:14","pubTimestamp":1788873260,"startTime":"0","endTime":"0","summary":"阿斯利康抗癌药物组合在晚期临床试验中达到主要生存目标路透9月8日-阿斯利康（AstraZeneca）AZN.L周二表示，其抗癌药物Imfinzi与安进（Amgen）的AMGN.O靶向免疫疗法Imdelltra联合使用，在一项晚期临床试验中，显著提高了广泛期小细胞肺癌一线治疗患者的总生存期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S450114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","BK4599","LU0997586515.USD","LU2237443465.HKD","LU0029864427.USD","LU0920783379.SGD","AZN.UK","BK4139","LU0058720904.USD","LU0122379950.USD","LU1863844749.USD","LU2091194634.USD","LU1084165304.USD","IBBQ","BIB","LU0545039389.USD","LU1487256676.USD","LU1829250122.USD","IBB","IE0034235188.USD","LU0957799991.USD","LU1061106388.HKD","LU0077335932.USD","LU1003076772.USD","LU0526926950.USD","LU1880407132.USD","AMGN","LU0969580561.USD","LU0203347892.USD","PBE","LU1023059063.AUD","TBXU","LU0109394709.USD","03165","LU0784383803.USD","LU0868494617.USD","LU0289739699.SGD","LU1046234339.USD","PJP","LU2279689827.SGD","LU2355687059.USD","LU0889566641.SGD","LU2433249047.HKD","LU1170363599.USD","LU0827474353.SGD","LU2242652126.USD","LU1923622614.USD","LU1481599808.USD","BBH","LU0661504455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115495471","title":"安進Phase 3 Dellphi-305研究重大突破：總生存期獲益顯著優於度伐利尤單抗單藥治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1115495471","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115495471?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:07","pubTimestamp":1788872830,"startTime":"0","endTime":"0","summary":"安进公司宣布，其Phase 3 Dellphi-305临床研究取得重大成果——与度伐利尤单抗单独用药相比，该疗法在总生存期上展现出显著且具有临床意义的改善。这一里程碑式的发现，无疑为肿瘤治疗领域注入了新的活力与希望。尽管完整的详细数据尚未全面披露，但安进方面表示，其临床意义及安全性特征将在即将召开的重大学术会议上进行详尽报告。安进公司并未止步于此。随着研发管线的持续推进，安进正逐步兑现其以创新疗法攻克严重疾病的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IE00BJT1NW94.SGD","PBE","TBXU","BK4566","LU0868494617.USD","LU2242652126.USD","IE00B4R5TH58.HKD","BK4534","IE00BFTCPJ56.SGD","LU1571399168.USD","BK4533","IE00BJJMRZ35.SGD","PJP","IE0009355771.USD","LU0320765992.SGD","BK4585","LU0109394709.USD","LU2112291526.USD","BK4581","LU0122379950.USD","IE0002141913.USD","BIB","BBH","LU1057294990.SGD","LU0889565916.HKD","IE00B2B36J28.USD","LU0289739699.SGD","LU0058720904.USD","SG9999001440.SGD","LU1983299246.USD","BK4599","LU2089984988.USD","BK4139","LU1023059063.AUD","AMGN","IBB","LU1061106388.HKD","LU2468319806.SGD","BK4588","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109517247","title":"Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1109517247","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109517247?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:04","pubTimestamp":1788872687,"startTime":"0","endTime":"0","summary":"Imdelltra®与Imfinzi®的联合疗法，于一线广泛期小细胞肺癌治疗领域，取得了具有划时代意义的总生存期提升。这一突破性进展，不仅为患者带来了新的曙光，也重塑了该领域的治疗格局。从数据层面观察，联合治疗方案的生存获益尤为显著，堪称里程碑式的成就。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU2242652126.USD","PJP","BK4533","LU1061106388.HKD","BK4139","LU0289739699.SGD","LU0122379950.USD","TBXU","SG9999001440.SGD","AMGN","BK4588","IE00BJJMRZ35.SGD","LU0058720904.USD","IE0009355771.USD","BK4534","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IBB","LU0889565916.HKD","BK4581","LU2112291526.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4566","BK4585","BIB","LU0109394709.USD","IBBQ","BK4599","BBH","LU2468319806.SGD","LU2089984988.USD","IE0002141913.USD","LU0868494617.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387373","title":"BMO下調安進及BioNTech評級至「與大市同步」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:59","pubTimestamp":1788872377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIB","LU1057294990.SGD","PBE","LU1571399168.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2089984988.USD","AMGN","LU2242652126.USD","BK4139","LU2468319806.SGD","LU1023059063.AUD","LU2112291526.USD","BK4585","IBB","PJP","LU1983299246.USD","LU0289739699.SGD","BBH","LU0058720904.USD","BK4566","IE0002141913.USD","TBXU","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2242646821.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4581","BK4599","BK4588","SG9999001440.SGD","LU0868494617.USD","LU0122379950.USD","BK4534","IBBQ","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378020","title":"苑東生物：公司將於9月16日參加科創板2026年半年度創新藥行業集體業績説明會","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378020","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378020?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:16","pubTimestamp":1788869760,"startTime":"0","endTime":"0","summary":"9月8日，苑东生物发布公告称，公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-08/doc-inircrnn9176436.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-08/doc-inircrnn9176436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688513","159992","KSTR","IBBQ","BK1574","MEDX","BK0239","06978","LNGR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320617","title":"禮邦醫藥-B(09637)：AP308治療IgA腎病的新藥臨床試驗申請獲美國食品藥品監督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320617","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320617?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:03","pubTimestamp":1788869000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，礼邦医药-B 发布公告，公司近日就AP308的新药临床试验申请获美国食品药品监督管理局批准，将启动一项AP308用于治疗IgA肾病的首次人体临床试验。就公司所知，AP308为首个获准开展临床试验的IgA蛋白酶类IgAN候选药物。该平台具有优异的稳定性及成药性，并可在保留蛋白酶对IgA1高效切割活性的同时，显著延长药物体内半衰期、降低肾脏清除并减弱免疫原性，为长效、低频次给药奠定基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","PSYK","09637","BK1574","IBBQ","159938","BMED","BK1161","159151","MDTX","IBBJ","BK1191","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332998","title":"美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103332998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%，报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备，并与ASML签订光罩尺寸升级合作协议，助力降低AI芯片制造成本。","market":"hk","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2041044095.USD","LU0823417653.USD","LU0056508442.USD","LU0541501648.USD","LU1093756325.SGD","OZEM","BK4141","LU0976567544.SGD","LU1069347547.HKD","LU2505996509.AUD","IE0004086264.USD","LU1804176565.USD","IGV","LU0070217475.USD","LU1983299246.USD","LU1150488218.USD","CGDG","LU0950375773.USD","LU2129689431.USD","LU0359202008.SGD","LU0889566641.SGD","LU0124676726.USD","LU0278409577.USD","SG9999013999.USD","LU2125154935.USD","BK4548","LU2087621335.USD","SGXZ57979304.SGD","BK4599","LU0061474960.USD","IE00BLSP4452.SGD","LU0345774391.USD","IE00BHPRN162.USD","LU1718418525.SGD","BK4535","LU0861579265.USD","LU1732800096.USD","LU0823414551.USD","LU2129689514.USD","LU0868494617.USD","IE00B19Z3581.USD","EFA","BK4526","LU2089283258.USD","LU2362541513.USD","LU2543165471.USD","IE00BQXX3C00.GBP","TTEQ","FDTX","LU2458330243.SGD","LU2360108059.USD","LU0868494708.USD","BK4566","SG9999001440.SGD","LU2023250504.SGD","LU2506951958.HKD","AIQ","LU0878005551.USD","LU0289739699.SGD","LU1803068979.SGD","SG9999014575.USD","XLE","BK4201","DDM","LU0130103400.USD","LU0823434583.USD","LU1064131342.USD","BBH","LUMA","LU2491050154.USD","LU1366192091.USD","LU2764262908.HKD","LU0300736062.USD","LU1989772923.USD","LU1585245621.USD","LU1778281490.HKD","FTXL","LU1066053197.SGD","LU2931357623.SGD","LU0345770308.USD","LU0234570918.USD","ADVE","LU0823416689.USD","LU1282649067.USD","QQQA","LU0795875086.SGD","03145","CHPX","LU2242649171.HKD","LU1894683348.USD","LU2430703251.USD","LU0654597011.USD","LEGR","LU2264538146.SGD","LU0545039389.USD","LU0081259029.USD","WEEI","BK4503","LU1868838027.USD","LU1992135472.HKD","LU1935042488.USD","PPH","LU0572939691.SGD","LU0345770993.USD","LU1282649810.SGD","INTW","LU2362540622.SGD","SPTE","BK4570","LU0368265418.SGD","LU1023057109.AUD","LU2211814178.USD","LU0211327993.USD","LU0965509101.SGD","LU2237443549.SGD","LU0476273544.USD","LU0122379950.USD","LU2360032135.SGD","LU0109392836.USD","BK4554","LU1868837565.USD","BK4528","IE00BQXX3F31.USD","LU1974910355.USD","BK5113","BK4007","PXI","IE00BFXG1179.USD","LU2063271972.USD","TRUN","AVEM","LU0238689110.USD","IE000SO60NU8.SGD","BK4097","LU2462611646.USD","SOXX","CHPS","SG9999002232.USD","LU0162691827.USD","LU2896262040.SGD","WQTM","LU0256863811.USD","LU0143863784.USD","LU2244417387.USD","LU0048573561.USD","SG9999000418.SGD","LU2487616109.SGD","LU0070302665.USD","LU1935043536.SGD","LU1046421795.USD","LU0957791311.USD","LU0251132253.USD","IE00BN8TJ469.HKD","IYE","EPAI","LU0345769631.USD","LU0444973449.USD","IXC","IE00BBT3K403.USD","LU1989764748.USD","LU2764263203.CNY","LU0466842654.USD","LU1267930227.SGD","LU0094547139.USD","CRAK","BK4534","BK4516","BLOX","BK4148",".DJI","LU2324357040.USD","LU1917777945.USD","ASIA","INT","LU1791710582.SGD","LU2505996681.GBP","LU0210528500.USD","IE00B7SZL793.SGD","QTUP","LU2473716301.USD","LU1861215975.USD","LU1435385759.SGD","LU2271345857.HKD","LU0738911758.USD","LU0882574055.USD","LU1935042991.SGD","LU0882747503.HKD","LU2102340556.USD","BK4578","LU0553294199.USD","BK4532","LU1815336760.USD","IE00B19Z4B17.USD","LU0742534661.SGD","LU2471134879.HKD","OILT","LU2089984988.USD","LU1582986359.USD","LU0359201612.USD","LU2023251221.USD","LU0965509010.AUD","ASMH","LU0496365809.HKD","BK4023","ERX","LU0274383776.USD","DBEF","LU2360106780.USD","LU1489326972.SGD","IE00BZ1G4Q59.USD","TDIV","IBBQ","IE00B5949003.HKD","LU0314106906.USD","LU0114720955.EUR","LU0143863198.USD","IE00BFXG0V08.USD","PQNT","LU0097036916.USD","LU0149725797.USD","LU1791710400.SGD","CHAT","IE0002141913.USD","LU0795875169.SGD","ORCU","LU0109394709.USD","LU2491049909.HKD","LU0648000940.SGD","CGNG","LU0072461881.USD","LU0208291251.USD","LU0266512127.USD","BK4504","LU0321505439.SGD","LU0157215616.USD","LU0823038988.USD","LU1935043023.USD","RSPG","DRIV","LU0942090050.USD","LU1929549753.HKD","LU0630314457.HKD","LU2108987350.USD","LU0345769128.USD","IFLR","LU2360107168.USD","LU1935042215.USD","IE00BMPRXQ63.HKD","LU2237443622.USD","LU2491050071.SGD","LU0011850046.USD","LU0417517546.SGD","LU0052756011.USD","LU0985489474.SGD","LU2720916845.USD","VDE","LU2357627491.SGD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU0084288322.USD","BIB","LU1150488135.SGD","SMH","CTEX","LU0170899867.USD","LU1712237335.SGD","LU1883866441.USD","BK4170","LU2430703178.SGD","LU2236285917.USD","LU0211328371.USD","LU2592432038.USD","LU1674673428.USD","LU2663582299.SGD","SPWO","HYDR","LU0541502299.USD","LU1674673691.USD","LU2111349929.HKD","LU2148611432.USD","IE00BD6J9T35.USD","LU0068578508.USD","LU2471134796.USD","IE00BZ199S13.USD","LU2357305700.SGD","LU0138981039.USD","AVXC","CNAV","IE00B7SZLL34.SGD","LU0889565916.HKD","LU2750360641.GBP","BK4157","LU1894683264.USD","FENI","BK4575","LU0211331839.USD","LU0345781412.USD","IE00BMPRXN33.USD","LU0868486357.SGD","LU0823039010.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","PJP","LU1571399168.USD","LU2506951875.HKD","OGIG","LU1366333091.USD","LU1323610961.USD","ESIM","LU0077335932.USD","LU0225283273.USD","IE000M9KFDE8.USD","LU1093756168.USD","LU2326559502.SGD","IE000BZT7R73.USD","TEK","LU1023059063.AUD","GNMX","LU0320765992.SGD","LU0058720904.USD","03165","LU1582987597.SGD","LU1003077747.HKD","LU2092937221.SGD","LU0642271901.SGD","IE00B1XK9C88.USD","IE0002270589.USD","LU0128525689.USD","LU0689626769.HKD","LU2089284900.SGD","LU1642822529.SGD","LU1989771016.USD","SG9999004220.SGD","SG9999002224.SGD","LU1720051017.SGD","IEO","LU1066051498.USD","LU0612318385.USD","LU0300736492.USD","SPY","LU2250418816.HKD","IE00B775SV38.USD","IE000WAW04H5.SGD","LU2028103732.USD","IE00BLSP4239.USD","LU1429558221.USD","LU0175139822.USD","LU0154245673.USD","LU0823421416.USD","LU0029874061.USD","LU2471134952.CNY","LU0965508806.USD","EMC","LU1153585028.USD","SG9999014567.USD","LU2272731782.SGD","LU2087625088.SGD","GXPE","SGXZ81514606.USD","LU0289960550.SGD","LU0264606111.USD","BK7095","BK4533","LU0154236417.USD","LU0878004406.USD","LU1057294990.SGD","ILOW","LU2054465674.USD","LU2237443382.USD","BK4538","LU1201861165.SGD","IE0009356076.USD","IE0031619046.USD","IE000MB6IJN5.SGD","DOG","LU2746668461.USD","LU1506573853.SGD","LU2764263039.SGD","BK4121","ORCX","AIS","FENY","LU1074936037.SGD","IEFA","SG9999011175.SGD","IE00BKVL7J92.USD","LU1732799900.SGD","DRLL","LU2602419157.SGD","BK4529","DIG","LU1989764664.SGD","IBB","HK0000304797.USD","LU0267386448.USD","IE00B3M56506.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU2471134523.USD","LU0321505868.SGD","BK4559","IE00B1BXHZ80.USD","IE00B2Q91V27.USD","LU2506952170.USD","IE0004445239.USD","LU0384037296.USD","THNR","LU0683600562.USD","LU2290526834.HKD","ORCL","LU1316542783.SGD","CQTM","LU0788109394.HKD","LU1548497426.USD","ORAC","BK4505","EGGY","LU1823568750.SGD","TINS","LU0433182093.SGD","DIA","WUGI","LU0488056044.USD","MEMX","DBEU","LU0234572021.USD","LU1720051108.HKD","FOTO","LU0348723411.USD","LU0210536198.USD","LU0203345920.USD","LINT","AVSE","BK4213","BK4605","BGIA","TEXU","LU0965509283.SGD","LU0320765489.SGD","IE0004091025.USD","PBE","BK4591","LU0612318971.USD","IE00B4R5TH58.HKD","LU2322448791.USD","LU0158827781.USD","LU0823414478.USD","LU2211815571.USD","DXD","LU2272731865.HKD","LU0211326755.USD","LU1037948897.HKD","LU0719512351.SGD","LU0456854461.SGD","LU2430703095.HKD","BK4608","MEDX","SG9999014542.SGD","LU1037948541.HKD","LU1508157978.USD","LU1211504680.USD","IE00B19Z3B42.SGD","LU2506951792.HKD","SGXZ51526630.SGD","PXE","LU2322448957.HKD","LU0130517989.USD","BK4543","LU0256331488.USD","LU0353189763.USD","LU1868837722.USD","LU2462591277.SGD","LU0359201885.HKD","LU1691799644.USD","LU0310800965.SGD","FTXN","IE0000B7K699.USD","BK4527","LU1861220033.SGD","LU0320765646.SGD","SG9999015358.SGD","BK4588","NVS","INYY","LU0353189680.USD","LU2954938101.SGD","BK4550","IE0034235303.USD","EMM","IGE","ORCS","SG9999001176.SGD","LU2237443978.SGD","IE00B3CCJ963.GBP","LU1582987324.SGD","LU1582986433.USD","LU0889565833.HKD","GNOM","CGGO","HBMX","LU2265009873.SGD","SG9999015341.SGD","TBXU","LU1430594728.SGD","LU1061106388.HKD","LU1934455194.USD","HK0000304805.HKD","LU0572940350.SGD","SG9999003800.SGD","IE00B3S45H60.SGD","LU2746668974.SGD","LU0431992006.USD","LU2294711713.HKD","LU0648001328.SGD","LU1048588211.SGD","LU2506952097.USD","SG9999001424.SGD","SDOW","LU0053666078.USD","BK4602","UDOW","LU0143551892.USD","LU0154245756.USD","CGIC","TNGY","SG9999014559.SGD","LU1934455277.USD","LU0859254822.USD","LU0198837287.USD","LU1815333072.USD","LU2498475776.HKD","IE0009355771.USD","LU0477156953.USD","LU1934455863.HKD","BK4581","LU0082616367.USD","LU2362541273.HKD","LU2860962120.EUR","LU2999663052.SGD","LU1989772840.SGD","LU2242646821.SGD","BK4592","LU2272731600.USD","LU2242652126.USD","LU0122376428.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU2237957902.USD","IE00BKPKM429.USD","CNEQ","IE00BQXX3D17.EUR","IE00BJJMRZ35.SGD","LU0957808578.USD","XNTK","LU0323591593.USD","LU2112291526.USD","LU0792757196.USD","LU2347655156.SGD","SG9999001176.USD","LU1992135399.USD","LU2133065610.SGD","SPRX","LU1430597077.USD","LU0203347892.USD","FFGX","LU0787776722.HKD","IE00BYQQ9H92.USD","LU0187121727.USD","INTC","LU1267930490.SGD","FCG","LU0661504455.SGD","LU1235294995.USD","LU2129689605.HKD","BK4612","LU0980610538.SGD","BK4082","LU1162221912.USD","BAI","LU0823421333.USD","LU1852331112.SGD","LU1623119135.USD","LU1734074674.USD","LU0949170772.SGD","LU0048584097.USD","IE00BGHQF524.EUR","LU0345774631.USD","LU0251142724.SGD","LU0266512473.USD","LU0823417737.USD","SG9999002521.SGD","IE00BMPRXR70.SGD","BK4512","LU0072462343.USD","LU0128526141.USD","GSID","BK4147","UMMA","BK4515","LU0823434740.USD","LU0098860793.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU2249611893.SGD","LU0158827948.USD","BK7104","LU2458330169.SGD","LU1035773651.USD","IE00BSNM7G36.USD","BK4579","LU2357125470.USD","LU1988902786.USD","LU2089985449.USD","BK4139","KNOW","LU0444971666.USD","LU0211326839.USD","LU2298321311.HKD","LU2750360997.AUD","CORO","LU1839511570.USD","LU2237957811.SGD","LU2468319806.SGD","LU0528227936.USD","LU1291159041.SGD","LU0130102774.USD","LU0266013472.USD","LU0251131958.USD","BK4138","BK4585","CWI","LU0912757837.SGD","LU0310799852.SGD","LU0345780950.USD","LU0878866978.SGD","ORCZ","IE00B5TLWC47.USD","IE000F7OJYX1.SGD","IE00B66KJ199.SGD","LU2247934214.USD","LU0316494557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320908","title":"AI 製藥迎來價值兑現期，創新藥產業打開全新增長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320908","media":"独角兽智库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320908?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 19:44","pubTimestamp":1788867840,"startTime":"0","endTime":"0","summary":"AI 制药行业已经走过早期概念炒作阶段，产业验证层级持续向上，从算法叙事正式转向管线价值兑现，行业商业化拐点正在加速到来。随着 AI 制药行业持续发展，生物测序数据需求持续扩张，设备与试剂业务打开增量空间，站在产业链上游充分受益行业整体景气上行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-08/doc-inircmes6042281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","BK1191","01477","MEDX","BK1161","LNGR","CHAT","IBBQ","06978","BK1574","AIPO","QTOC","AGIX","ARTY","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324003","title":"PHARVARIS的3期臨床試驗達到全部主要及次要終點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324003","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324003?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:53","pubTimestamp":1788864791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","BMED","IBBJ","PSYK","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329150","title":"石藥集團：SYH2083滴眼液獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329150","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329150?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:51","pubTimestamp":1788861091,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","PSYK","IBBQ","BMED","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":7,"totalSize":215,"code":"91000000","status":"200"}]}}